It is noteworthy that both CAD and DM2 are independently thought to be characterized by endothelial dysfunction [19,29,30], and an elevation in soluble E-selectin levels has been identified as a biomarker for both disorders. The gene discussed is SELE; the disease is endothelial dysfunction.